These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11499141)

  • 1. [Pneumococcal infections. New vaccine protects even young children].
    Meissner T
    MMW Fortschr Med; 2001 Jul; 143(28-29):17. PubMed ID: 11499141
    [No Abstract]   [Full Text] [Related]  

  • 2. [International studies again confirm the positive effects of pneumococcal vaccinations].
    Bilic S
    Kinderkrankenschwester; 2006 Aug; 25(8):322-3. PubMed ID: 16937827
    [No Abstract]   [Full Text] [Related]  

  • 3. A pneumococcal conjugate vaccine for infants and children.
    Med Lett Drugs Ther; 2000 Mar; 42(1074):25-7. PubMed ID: 10776409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of the heptavalent pneumococcal vaccine against meningitis, pneumonia and acute otitis media in pediatric age. Theoretical coverage offered by the heptavalent conjugate vaccine in Italy].
    Principi N; Esposito S
    Ann Ig; 2002; 14(6 Suppl 7):21-30. PubMed ID: 12638361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine.
    Casado-Flores J; Rodrigo C; Arístegui J; Martínón JM; Fenoll A; Mendez C
    Pediatr Infect Dis J; 2008 Nov; 27(11):1020-2. PubMed ID: 18845983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Life threatening bacterial meningitis. How it can be prevented, when it should be considered (interview by Dr. Thomas Meissner)].
    Dittmann S
    MMW Fortschr Med; 2007 Mar; 149(12):15. PubMed ID: 17674882
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM; Geelen SP; Sanders EA; Wolfs TF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal vaccination: yes or no.
    Sharda KB
    Indian Pediatr; 2008 Jun; 45(6):519. PubMed ID: 18599950
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
    Heininger U
    Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
    [No Abstract]   [Full Text] [Related]  

  • 13. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
    Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
    Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
    Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expected benefits of pneumococcal vaccination in Canadian infants and children < 5 years old.
    Can Commun Dis Rep; 2006 Mar; 32(5):45-54. PubMed ID: 16649291
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic approaches in children immunized with vaccine Prevenar].
    Cohen R; Aujard Y; Bingen E; Boucherat M; Bourrillon A; Foucaud P; Francois M; Garnier JM; Guillot M; Ovetchkine P; Ployet MJ; Quinet B; Gaudelus J
    Arch Pediatr; 2002 Jan; 9(1):4-6. PubMed ID: 11865548
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of pneumococcal vaccination of patients with cochlear implants.
    Rose M; Hey C; Kujumdshiev S; Gall V; Schubert R; Zielen S
    J Infect Dis; 2004 Aug; 190(3):551-7. PubMed ID: 15243931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [7-valent conjugate Pneumococcal vaccine and nasopharyngeal cavity].
    Piffer S
    Ann Ig; 2002; 14(6 Suppl 7):31-7. PubMed ID: 12638362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.